logo

For the Inventor, By the Inventor

Kawasaki, Japan

Yasuki Mori

This inventor holds 17 USPTO granted patents, primarily in Antibiotic Derivatives. Top assignees: Abbott Laboratories Corporation, Kyowa Hakko Kogyo Co., Ltd., Sagami Chemical Research Center. Active years: 1977-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuki Mori. Retrieved from https://idiyas.com/inventor/yasuki-mori-q9os00md

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 69(Granted Patents)


Location History:

  • Kawasaki, JA (1977 - 1978)
  • Kawasaki, JP (1979 - 1982)

Company Filing History:

goldMedal15 out of 4,189 
 
Abbott Laboratories Corporation
 patents
silverMedal2 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents
bronzeMedal1 out of 191 
 
Sagami Chemical Research Center
 patents
where one patent can have more than one assignee

Years Active: 1977-1982

Loading Chart...
Areas of Expertise:
Fortimicin B
Fortimicin C
Antibiotic Derivatives
XK-88-5
XK-62-2
Production Process
Deamino Compounds
Aminoglycosides
Novel Derivatives
Chemical Synthesis
Pharmaceuticals
Antibiotic Production
17 patents (USPTO):Explore Patents
1. 4339572 - Fortimicin B derivatives and process for production thereof (1982-07-13),
2. 4237272 - Derivatives of fortimicin A (1980-12-02),
3. 4237269 - Derivatives of fortimicin A (1980-12-02),
4. 4226980 - Novel derivatives of fortimicin B and process for preparing same (1980-10-07),
5. 4220755 - Fortimicin B derivatives and process for production thereof (1980-09-02),
6. 4216309 - 1-N-Acyl-aminoglycoside-XK-88-5 (1980-08-05),
7. 4195171 - Derivatives of an antibiotic XK-62-2 and process for the production (1980-03-25),
8. 4169942 - Fortimicin derivatives and method for production thereof (1979-10-02),
9. 4169941 - Derivatives of XK-88-5 and process for the production thereof (1979-10-02),
10. 4145530 - 2'-Deamino-3'-epiamino-3'-deoxy-XK-88-5 and process for the production (1979-03-20),
11. 4132846 - 1-N-(.alpha.-Hydroxy-.beta.-aminopropionyl) XK-62-2 and method of (1979-01-02),
12. 4097664 - Derivatives of an antibiotic XK-62-2 (1978-06-27),
13. 4097428 - Fortimicin C and process for production thereof (1978-06-27),
14. 4076931 - Derivatives of an antibiotic XK-62-2 and the process for the production (1978-02-28),
15. 4055715 - Method of producing (1977-10-25),

Title: **Yasuki Mori: A Pioneer in Antibiotic Innovations**

Introduction

Yasuki Mori is a prolific inventor based in Kawasaki, Japan, known for his significant contributions to the field of antibiotics. With a remarkable portfolio of 17 patents, Mori's work revolves around enhancing and producing innovative antibiotic compounds. His groundbreaking efforts have not only advanced pharmaceutical science but have also opened new avenues for the treatment of bacterial infections.

Latest Patents

Among Yasuki Mori's latest patents is the “Fortimicin B derivatives and process for production thereof.” This invention focuses on novel 4-N-substituted derivatives of the antibiotic Fortimicin B and includes a unique method for its semi-synthetic production, particularly of Fortimicin C. Another noteworthy patent involves the “Derivatives of Fortimicin A,” where Mori developed semisynthetic antibacterial compounds through the chemical modification of the naturally occurring antibiotic compound fortimicin A. These inventions highlight his commitment to improving antibiotic efficacy and production methods.

Career Highlights

Mori has had a substantial impact on the pharmaceutical industry throughout his career. He has worked for prominent companies such as Abbott Laboratories Corporation and Kyowa Hakko Kogyo Co., Ltd. His expertise in antibiotic innovation has led to significant advancements in treating bacterial infections, showcasing his role as a leading inventor in this crucial area of healthcare.

Collaborations

Throughout his career, Yasuki Mori has collaborated with esteemed professionals like Moriyuki Sato and Shinji Tomioka. These partnerships have allowed for a rich exchange of ideas and innovation, further contributing to the development of novel antibiotics and enhancing the field's overall knowledge base.

Conclusion

In conclusion, Yasuki Mori stands out as a remarkable inventor whose work in antibiotic development has had a lasting impact. His patents reflect his innovative thinking and dedication to addressing pressing health challenges through advanced pharmaceutical solutions. As antibiotic resistance continues to be a global concern, contributions like those of Mori are invaluable in the quest for effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…